Description
A CRTH2/DP2 receptor antagonist (Kd = 1.14 nM) with a relatively slow dissociation rate (half-life = 14.4 minutes); inhibits PGD2-stimulated human eosinophil shape change in whole blood assays and PGD2-induced cytokine release in human Th2 cells
Formal name: 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1 H -pyrrolo[2,3b]pyridine-3-acetic acid
Synonyms: NVP-QAW039|QAW039
Molecular weight: 426.4
CAS: 872365-14-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway